BR9509421A - Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos - Google Patents

Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos

Info

Publication number: BR9509421A
Authority: BR; Brazil
Prior art keywords: therapeutic; diagnostic; sequences; prophylactic agents; virus genotype
Prior art date: 1994-10-21

Application number

BR9509421A

Other languages

English (en)

Inventor

Geert Maertens

Lieven Stuyver

Original Assignee

Innogenetics Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-21

Filing date

1995-10-23

Publication date

1997-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26137782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9509421(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-10-23 Application filed by Innogenetics Nv filed Critical Innogenetics Nv

1997-09-30 Publication of BR9509421A publication Critical patent/BR9509421A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR9509421A 1994-10-21 1995-10-23 Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos BR9509421A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP94870166		1994-10-21
EP95870076		1995-06-28
PCT/EP1995/004155 WO1996013590A2 (en)	1994-10-21	1995-10-23	New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents

Publications (1)

Publication Number	Publication Date
BR9509421A true BR9509421A (pt)	1997-09-30

Family

ID=26137782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9509421A BR9509421A (pt)	1994-10-21	1995-10-23	Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos

Country Status (12)

Country	Link
US (2)	US7129337B1 (pt)
EP (2)	EP0804584B2 (pt)
JP (2)	JPH10507643A (pt)
AT (1)	ATE218617T1 (pt)
AU (1)	AU702436B2 (pt)
BR (1)	BR9509421A (pt)
CA (1)	CA2201703A1 (pt)
DE (1)	DE69526973T3 (pt)
DK (1)	DK0804584T3 (pt)
ES (1)	ES2176342T5 (pt)
PT (1)	PT804584E (pt)
WO (1)	WO1996013590A2 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9620075D0 (en) *	1996-09-26	1996-11-13	Dynal As	Method
US7078500B1 (en) *	1998-01-30	2006-07-18	The General Hospital Corporation	Genetic immunization with nonstructural proteins of hepatitis C virus
KR20010042807A (ko)	1998-04-17	2001-05-25	피. 아페르몬트	환원제를 사용하는 개선된 면역진단 분석법
AU4497999A (en) *	1998-04-28	1999-11-16	Ingrid-Corina Bergter	Radioimmunopharmaca for treating hepatitis c
DE69922958T3 (de) *	1998-06-24	2008-06-26	Innogenetics N.V.	Hcv hüllproteine partikel : verwendung für therapeutische impfung
RU2286172C2 (ru) *	2000-08-17	2006-10-27	Трипеп Аб	Вакцины, содержащие рибавирин, и способы их использования
PL360990A1 (en) *	2000-08-17	2004-09-20	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) *	2000-08-17	2006-04-04	Tripep Ab	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en)	2000-08-29	2004-01-20	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US7101561B2 (en)	2000-12-01	2006-09-05	Innogenetics N.V.	Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
GB0126782D0 (en) *	2001-11-07	2002-01-02	Medical Res Council	Assay
US8124747B2 (en) *	2003-08-29	2012-02-28	Innogenetics	HCV clade and prototype sequences thereof
JP5138230B2 (ja)	2004-01-07	2013-02-06	サード・ウェーブ・テクノロジーズ・インク	Ｃ型肝炎ウイルスの遺伝子型の決定方法
RU2267496C2 (ru) *	2004-01-15	2006-01-10	Сергей Иванович Черныш	Противоопухолевые и антивирусные пептиды
CA2618429A1 (en) *	2005-05-25	2007-03-22	Tripep Ab	A hepatitis c virus non-structural ns3/4a fusion gene
US7919242B2 (en)	2005-06-30	2011-04-05	Roche Molecular Systems, Inc.	Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
KR101505201B1 (ko)	2005-12-12	2015-03-24	에이씨 이뮨 에스.에이.	치료적 특성을 갖는 베타 1-42 특이적인 단일클론성 항체
EP2046833B9 (en)	2006-07-14	2014-02-19	AC Immune S.A.	Humanized antibody against amyloid beta
ME01758B (me)	2006-07-14	2014-09-20	Genentech Inc	Humanizirano protutijelo protiv amiloida beta
CN101563362B (zh) *	2006-08-25	2015-02-11	麦克法兰布奈特医疗研究与公共健康研究所有限公司	重组hcv e2糖蛋白
EP2527474A1 (en)	2006-10-20	2012-11-28	Innogenetics N.V.	Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
US20090325145A1 (en)	2006-10-20	2009-12-31	Erwin Sablon	Methodology for analysis of sequence variations within the hcv ns5b genomic region
MX2009005279A (es)	2006-11-24	2009-05-28	Ac Immune Sa	Derivados de n-(metil)-1h-pirazol-3-amina, n-(metil)-piridin-2-ami na y n-(metil)-tiazol-2-amina para el tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide, tal como por ejemplo alzheimer.
WO2008156621A1 (en)	2007-06-12	2008-12-24	Ac Immune S.A.	Monoclonal anti beta amyloid antibody
KR20150055103A (ko)	2007-06-12	2015-05-20	에이씨 이뮨 에스.에이.	아밀로이드 베타에 대해 인간화된 항체
EP2236624B1 (en) *	2007-08-09	2012-11-07	Federalnoe Gosudarstvennoe Byudzhetnoe Uchrezhdenie Nauki Institut Molekulyarnoi Biologi Im. V.A. Engelgardta Rossiiskoi Akademii Nauk	Method for identifying the genotype and subtype of hepatitis c virus on a biological microchip
EP2185195A2 (en)	2007-08-16	2010-05-19	Tripep Ab	Immunogen platform
CN101998863B (zh)	2007-10-05	2015-09-16	基因技术公司	抗淀粉状蛋白β抗体在眼病中的用途
WO2009130588A2 (en) *	2008-04-22	2009-10-29	Tripep Ab	Immunogen platform
EP2311823A1 (en)	2009-10-15	2011-04-20	AC Immune S.A.	2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
ES2734552T3 (es)	2010-04-16	2019-12-10	Ac Immune Sa	Compuestos novedosos para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide
US20110256064A1 (en)	2010-04-16	2011-10-20	Ac Immune, S.A.	Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
US8962241B2 (en) *	2010-07-20	2015-02-24	California Institute Of Technology	Triggered molecular geometry based bioimaging probes
MX341369B (es)	2010-07-30	2016-08-17	Genentech Inc *	Anticuerpo anti-beta-amiloide humanizado seguro y funcional.
WO2012045882A2 (en)	2010-10-07	2012-04-12	Ac Immune S.A.	Pharmaceutical composition
US9687447B2 (en)	2010-10-26	2017-06-27	Ac Immune S.A.	Method for preparing liposome-based constructs
CN104080806B (zh)	2011-10-07	2018-01-19	Ac免疫有限公司	识别Tau的磷酸化特异抗体
SG11201406347TA (en)	2012-04-05	2014-11-27	Ac Immune Sa	Humanized tau antibody
AU2013270684B2 (en)	2012-06-08	2018-04-19	Sutro Biopharma, Inc.	Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
DK2863955T3 (en)	2012-06-26	2017-01-23	Sutro Biopharma Inc	MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF
CN102766701B (zh) *	2012-07-04	2016-05-04	福州泰普生物科学有限公司	丙型肝炎病毒基因分型的试剂盒及方法
EP3584255B1 (en)	2012-08-31	2022-02-16	Sutro Biopharma, Inc.	Modified amino acids comprising an azido group
CA2902910A1 (en)	2013-03-15	2014-09-25	Ac Immune S.A.	Anti-tau antibodies and methods of use
US9891225B2 (en) *	2013-05-10	2018-02-13	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Compositions and methods for simultaneous detection of HCV antigen/antibody
ES2865473T3 (es)	2013-07-10	2021-10-15	Sutro Biopharma Inc	Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
KR102512797B1 (ko)	2013-09-05	2023-03-22	에이비2 바이오 에스에이	염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ)
US9840493B2 (en)	2013-10-11	2017-12-12	Sutro Biopharma, Inc.	Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
CN107660150B (zh)	2015-03-05	2023-10-24	Ab2生物股份有限公司	Il-18结合蛋白(il-18bp)和抗体在炎性疾病中
US11098107B2 (en)	2016-06-15	2021-08-24	Sutro Biopharma, Inc.	Antibodies with engineered CH2 domains, compositions thereof and methods of using the same
GB201807367D0 (en)	2018-05-04	2018-06-20	Univ Newcastle	Biomarker
EP4114852A1 (en)	2020-03-03	2023-01-11	Sutro Biopharma, Inc.	Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
US20230173021A1 (en)	2020-05-06	2023-06-08	Ab2 Bio Sa	IL-18 Binding Protein (IL-18BP) In Respiratory Diseases
EP3943097A1 (en)	2020-07-24	2022-01-26	AB2 Bio SA	Car-t cell therapy
WO2023166206A1 (en)	2022-03-04	2023-09-07	Ab2 Bio Sa	Il-18 binding protein (il-18bp) in the treatment of vexas
WO2024006563A1 (en)	2022-07-01	2024-01-04	Sutro Biopharma, Inc.	Il-12 mutants with reduced toxicity, compositions thereof and methods of using the same
WO2024044780A1 (en)	2022-08-26	2024-02-29	Sutro Biopharma, Inc.	Interleukin-18 variants and uses thereof
WO2024098023A2 (en)	2022-11-04	2024-05-10	Sutro Biopharma, Inc.	Interferon alpha polypeptides and conjugates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU225068B1 (en)	1989-03-17	2006-05-29	Chiron Corp	Process for producing diagnostics and vaccine of nanbh
WO1991004262A1 (en)	1989-09-15	1991-04-04	National Institute Of Health Of Japan	New hcv isolates
US5372928A (en)	1989-09-15	1994-12-13	Chiron Corporation	Hepatitis C virus isolates
SE9004010D0 (sv)	1989-12-18	1990-12-17	Wellcome Found	Viralt medel
AU652941B2 (en)	1990-06-25	1994-09-15	Research Foundation For Microbial Diseases Of Osaka University, The	Non-A, Non-B hepatitis virus particles
RO117267B1 (ro)	1991-05-08	2001-12-28	Chiron Corp	Secventa de acid nucleic si peptida codificata de aceasta, pentru diagnostic si tratament
WO1993000365A2 (en) *	1991-06-24	1993-01-07	Chiron Corporation	Hepatitis c virus (hcv) polypeptides
EP0532167A3 (en)	1991-08-09	1993-03-31	Immuno Japan Inc.	Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
WO1993006126A1 (en) *	1991-09-13	1993-04-01	Chiron Corporation	Immunoreactive hepatitis c virus polypeptide compositions
EP0610436B9 (en)	1991-11-21	2003-03-26	Common Services Agency	Hepatitis-c virus testing
NZ266148A (en) *	1993-04-27	1997-06-24	Innogenetics Sa Nv	Polynucleic acid compositions of hepatitis c virus sequences, hcv protein compositions and uses of both
JPH06319563A (ja) *	1993-05-13	1994-11-22	Imuno Japan:Kk	Ｃ型肝炎ウイルス遺伝子、オリゴヌクレオチド、並びにｃ型肝炎ウイルス遺伝子型判定方法
US5514539A (en)	1993-06-29	1996-05-07	The United States Of America As Represented By The Department Of Health And Human Services	Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines

1995
- 1995-10-23 US US08/836,075 patent/US7129337B1/en not_active Expired - Fee Related
- 1995-10-23 ES ES95936537T patent/ES2176342T5/es not_active Expired - Lifetime
- 1995-10-23 AT AT95936537T patent/ATE218617T1/de not_active IP Right Cessation
- 1995-10-23 DE DE69526973T patent/DE69526973T3/de not_active Expired - Lifetime
- 1995-10-23 BR BR9509421A patent/BR9509421A/pt not_active Application Discontinuation
- 1995-10-23 AU AU38440/95A patent/AU702436B2/en not_active Ceased
- 1995-10-23 EP EP95936537A patent/EP0804584B2/en not_active Expired - Lifetime
- 1995-10-23 EP EP00118731A patent/EP1076092A3/en not_active Withdrawn
- 1995-10-23 JP JP8514299A patent/JPH10507643A/ja active Pending
- 1995-10-23 CA CA002201703A patent/CA2201703A1/en not_active Abandoned
- 1995-10-23 PT PT95936537T patent/PT804584E/pt unknown
- 1995-10-23 WO PCT/EP1995/004155 patent/WO1996013590A2/en active IP Right Grant
- 1995-10-23 DK DK95936537T patent/DK0804584T3/da active
2001
- 2001-05-09 US US09/851,138 patent/US6974864B2/en not_active Expired - Fee Related
2004
- 2004-10-20 JP JP2004305574A patent/JP2005118044A/ja active Pending

Also Published As

Publication number	Publication date
AU702436B2 (en)	1999-02-18
DK0804584T3 (da)	2002-09-23
PT804584E (pt)	2002-11-29
US6974864B2 (en)	2005-12-13
DE69526973T3 (de)	2010-01-07
US7129337B1 (en)	2006-10-31
CA2201703A1 (en)	1996-05-09
DE69526973T2 (de)	2003-01-02
ES2176342T5 (es)	2010-02-09
US20020183508A1 (en)	2002-12-05
WO1996013590A3 (en)	1996-08-15
WO1996013590A2 (en)	1996-05-09
ES2176342T3 (es)	2002-12-01
EP0804584B2 (en)	2008-07-09
ATE218617T1 (de)	2002-06-15
EP0804584A1 (en)	1997-11-05
DE69526973D1 (de)	2002-07-11
EP0804584B1 (en)	2002-06-05
EP1076092A2 (en)	2001-02-14
JP2005118044A (ja)	2005-05-12
EP1076092A3 (en)	2001-03-28
AU3844095A (en)	1996-05-23
JPH10507643A (ja)	1998-07-28

Publication	Publication Date	Title
BR9509421A (pt)	1997-09-30	Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos
BR9405334A (pt)	1999-05-25	Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
ATE507312T1 (de)	2011-05-15	Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
FI924396A0 (fi)	1992-09-30	Diagnostiska aemnen.
ES2101388T3 (es)	1997-07-01	Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
DE69015261D1 (de)	1995-02-02	Verfahren zum Nachweis des humanen Papillomvirus.
ATE303597T1 (de)	2005-09-15	Hcv mosaik antigen zusammensetzung
FI951198A0 (fi)	1995-03-15	Uudet haaroittuneet hybridi- ja ryhmäpeptidit, jotka ovat tehokkaita non-A, non-B-hepatiitin diagnostisoinnissa ja paljastamisessa
ES2141094T3 (es)	2000-03-16	Deteccion directa del arn del virus de la hepatitis c.
DE69034218D1 (de)	2006-05-18	Impfstoff und Diagnostikum für den Schweine-Cholera-Virus
DE69011122D1 (de)	1994-09-01	Rubella-e1 und c peptide.
DE60029327D1 (de)	2006-08-24	Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE68926245D1 (de)	1996-05-15	Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
ATE482974T1 (de)	2010-10-15	Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
DE69629121D1 (de)	2003-08-21	Verwendung eines 24 kD Proteins zur Behandlung und Diagnose einer HCV Infektion
ATE279727T1 (de)	2004-10-15	Diagnosekit für hauttest und verfahren zur durchführung desselben
ATE540052T1 (de)	2012-01-15	Neue peptide, die epitope des humanen herpesvirus 8 darstellen
DE59008558D1 (de)	1995-04-06	Verfahren zur Bestimmung von Antikörpern gegen Erreger von Infektionskrankheiten in Körperflüssigkeiten, Mittel dazu und ihre Verwendung in diesem Verfahren.
TW369600B (en)	1999-09-11	Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
FR2618782B1 (fr)	1991-04-26	Sondes d'acides nucleiques des virus de papillome humain

Legal Events

Date	Code	Title	Description
2002-12-17	EG	Technical examination (opinion): publication of technical examination (opinion)
2004-08-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2004-12-21	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2005-11-16	B09B	Patent application refused [chapter 9.2 patent gazette]
2005-11-22	B09R	Decision of refusal: republication [chapter 9.2.3 patent gazette]	Free format text: DE ACORDO COM O ART. 37 DA LPI, SUGIRO O INDEFERIMENTO DO PRESENTE PEDIDO, COM BASE NOS ARTS. 8O, 10 (IX) E 13 BEM COMO NO ART. 25 DA LPI VIGENTE.
2006-04-04	B12B	Appeal against refusal [chapter 12.2 patent gazette]